Aurobindo Pharma shares fall after USFDA issues 10 observations to API unit in Telangana

September 30, 2024
Uncategorized

The Hyderabad-based pharmaceutical manufacturing company said the observations are of procedural in nature and will be responded to within the stipulated time.

Aurobindo Pharma shares fall after USFDA issues 10 observations to API unit in Telangana

Leave a ReplyCancel Reply

NSE to stop F&O contracts on Aarti Industries, Birlasoft, and 3 others from August 1

Gulf Oil Lubricants Q4 Results: Profit up, revenue rises 10% YoY; proposes ₹28 dividend

IndusInd Bank board to submit CEO picks to RBI before June end

NBCC bags ₹162-crore interior work contract in Delhi’s World Trade Centre

Shiprocket files confidential DRHP with SEBI to raise nearly ₹2,500 crore in IPO: Sources